EurimPharm Arzneimittel GmbH
EurimPharm Arzneimittel GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a trusted provider of high-quality generic medicines and innovative healthcare solutions. EurimPharm focuses on a diverse range of therapeutic areas, including pain management, cardiovascular health, and infectious diseases, offering a portfolio that stands out for its commitment to quality and affordability. With a strong emphasis on research and development, the company has achieved significant milestones, enhancing its market position as a reliable supplier in the competitive pharmaceutical landscape. Recognised for its dedication to patient care and safety, EurimPharm continues to expand its reach, ensuring that effective treatments are accessible to healthcare providers and patients alike.
DitchCarbon Score
How does EurimPharm Arzneimittel GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
EurimPharm Arzneimittel GmbH's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
EurimPharm Arzneimittel GmbH's reported carbon emissions
EurimPharm Arzneimittel GmbH, headquartered in Germany, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions or any established reduction targets. Despite the absence of concrete emissions data, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and climate commitments. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at reducing their carbon footprint. EurimPharm may be aligning with these industry trends, although specific commitments or initiatives have not been disclosed. As the company progresses, it will be crucial for EurimPharm to establish measurable climate goals and report on their emissions to contribute effectively to global climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
EurimPharm Arzneimittel GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
